Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5314796

SELVACOVATEIN
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available

Basic Information

ChEMBL ID CHEMBL5314796
Name SELVACOVATEIN
Phase Approved
Structure Type SEQ
Therapeutic ✓ Yes

Known Names

Bimervax Selvacovatein Selvacovateina Selvacovateine
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
4
Known Names
2
Indications
1
Mechanisms

Drug Information

Molecule Type Protein
First Approval 2023
Availability Unknown
Chirality Single Enantiomer

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Spike glycoprotein vaccine antigen VACCINE ANTIGEN Spike glycoprotein

Indications

COVID-19 Vaccination

Data from ChEMBL 36 via Core Engine